Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 3
1995 9
1996 20
1997 9
1998 14
1999 14
2000 24
2001 25
2002 31
2003 33
2004 46
2005 49
2006 65
2007 68
2008 49
2009 51
2010 51
2011 70
2012 61
2013 40
2014 39
2015 31
2016 44
2017 41
2018 49
2019 34
2020 52
2021 45
2022 40
2023 25
2024 24

Text availability

Article attribute

Article type

Publication date

Search Results

1,050 results

Results by year

Filters applied: . Clear all
Page 1
Risperidone for bipolar disorders.
Sajatovic M, Madhusoodanan S, Fuller MA, Aulakh L, Keaton DB. Sajatovic M, et al. Expert Rev Neurother. 2005 Mar;5(2):177-87. doi: 10.1586/14737175.5.2.177. Expert Rev Neurother. 2005. PMID: 15853488 Review.
A number of controlled and open-label treatment trials have shown risperidone's efficacy and tolerability in the manic phase of bipolar disorder. Risperidone has also been reported to be useful in the longer-term treatment of bipolar disorder. . …
A number of controlled and open-label treatment trials have shown risperidone's efficacy and tolerability in the manic phase o …
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Kishi T, Ikuta T, Matsuda Y, Sakuma K, Okuya M, Nomura I, Hatano M, Iwata N. Kishi T, et al. Mol Psychiatry. 2022 Feb;27(2):1136-1144. doi: 10.1038/s41380-021-01334-4. Epub 2021 Oct 12. Mol Psychiatry. 2022. PMID: 34642461 Free PMC article.
Compared with the placebo, aripiprazole, asenapine, carbamazepine, cariprazine, haloperidol, lithium, olanzapine, paliperidone, quetiapine, risperidone, tamoxifen, valproate, and ziprasidone outperformed response to treatment (N = 56, n = 14503); aripiprazole, olanzapine, …
Compared with the placebo, aripiprazole, asenapine, carbamazepine, cariprazine, haloperidol, lithium, olanzapine, paliperidone, quetiapine, …
Risperidone treatment of bipolar mania.
Nguyen LN, Guthrie SK. Nguyen LN, et al. Ann Pharmacother. 2006 Apr;40(4):674-82. doi: 10.1345/aph.1G378. Epub 2006 Mar 28. Ann Pharmacother. 2006. PMID: 16569811 Review.
OBJECTIVE: To review clinical trial evidence regarding the efficacy and safety of risperidone for the treatment of bipolar mania. DATA SOURCES: Articles were identified through searches of PubMed (1950-August 2005), EMBASE (1988-August 2005 week 37), and Internation …
OBJECTIVE: To review clinical trial evidence regarding the efficacy and safety of risperidone for the treatment of bipolar man …
Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials.
Nestsiarovich A, Gaudiot CES, Baldessarini RJ, Vieta E, Zhu Y, Tohen M. Nestsiarovich A, et al. Eur Neuropsychopharmacol. 2022 Jan;54:75-89. doi: 10.1016/j.euroneuro.2021.08.264. Epub 2021 Sep 3. Eur Neuropsychopharmacol. 2022. PMID: 34489127 Free article. Review.
Uncertainty remains regarding the relative efficacy of maintenance pharmacotherapy for bipolar disorder (BD), and available data require updating. The present systematic review and meta-analysis aims to consolidate the evidence from the highest quality randomized controlle …
Uncertainty remains regarding the relative efficacy of maintenance pharmacotherapy for bipolar disorder (BD), and available data requ …
Risperidone: a review of its use in the treatment of bipolar mania.
Fenton C, Scott LJ. Fenton C, et al. CNS Drugs. 2005;19(5):429-44. doi: 10.2165/00023210-200519050-00005. CNS Drugs. 2005. PMID: 15907153 Review.
Risperidone is now approved in the UK and the US for use in bipolar mania. ...Risperidone, as monotherapy or combined therapy with lithium or valproate semisodium, is an effective treatment option in bipolar mania....
Risperidone is now approved in the UK and the US for use in bipolar mania. ...Risperidone, as monotherapy or combined t
Risperidone in long-term treatment for bipolar disorder.
Rendell JM, Geddes JR. Rendell JM, et al. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD004999. doi: 10.1002/14651858.CD004999.pub2. Cochrane Database Syst Rev. 2006. PMID: 17054229 Review.
There is a need for evidence of the effectiveness and safety of risperidone as long-term treatment. OBJECTIVES: To assess the randomised evidence for the efficacy and tolerability of risperidone compared with placebo or other active pharmacological treatments as lon …
There is a need for evidence of the effectiveness and safety of risperidone as long-term treatment. OBJECTIVES: To assess the randomi …
Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder.
Fagiolini A, Casamassima F, Mostacciuolo W, Forgione R, Goracci A, Goldstein BI. Fagiolini A, et al. Expert Opin Pharmacother. 2010 Jul;11(10):1727-40. doi: 10.1517/14656566.2010.490831. Expert Opin Pharmacother. 2010. PMID: 20486830 Review.
AREAS COVERED IN THIS REVIEW: This paper comprises a review and commentary regarding the use of risperidone LAI in bipolar disorder. WHAT THE READER WILL GAIN: The reader will gain an understanding regarding the risks and benefits of risperidone LAI in bip
AREAS COVERED IN THIS REVIEW: This paper comprises a review and commentary regarding the use of risperidone LAI in bipolar dis …
Risperidone long-acting injection: in bipolar I disorder.
Deeks ED. Deeks ED. Drugs. 2010 May 28;70(8):1001-12. doi: 10.2165/11204480-000000000-00000. Drugs. 2010. PMID: 20481656 Review.
A long-acting intramuscular formulation of the atypical antipsychotic agent risperidone is now indicated for the maintenance treatment of patients with bipolar I disorder. ...Moreover, fluctuations in plasma drug concentrations at steady state were 1.7-fold lower wi …
A long-acting intramuscular formulation of the atypical antipsychotic agent risperidone is now indicated for the maintenance treatmen …
Long-acting risperidone: a review of its role in the treatment of bipolar disorder.
Kemp DE, Canan F, Goldstein BI, McIntyre RS. Kemp DE, et al. Adv Ther. 2009 Jun;26(6):588-99. doi: 10.1007/s12325-009-0039-0. Epub 2009 Jun 26. Adv Ther. 2009. PMID: 19562274 Free PMC article. Review.
Bipolar disorder is a multidimensional illness typified by fluctuating periods of depression and mania, cognitive dysfunction, abnormal circadian rhythms, and multiple comorbid psychiatric and general medical conditions. ...This article will provide a succinct review of th
Bipolar disorder is a multidimensional illness typified by fluctuating periods of depression and mania, cognitive dysfunction, abnorm
Classics in Chemical Neuroscience: Risperidone.
Chopko TC, Lindsley CW. Chopko TC, et al. ACS Chem Neurosci. 2018 Jul 18;9(7):1520-1529. doi: 10.1021/acschemneuro.8b00159. Epub 2018 May 11. ACS Chem Neurosci. 2018. PMID: 29695153 Review.
Despite initial Food and Drug Administration approval 25 years ago, risperidone continues to be a fundamental treatment for schizophrenia, bipolar I disorder, and autism-related irritability. ...In this review, we highlight the history and importance of risperido
Despite initial Food and Drug Administration approval 25 years ago, risperidone continues to be a fundamental treatment for schizophr …
1,050 results